VV ECMO Indications: When Is Veno-Venous ECMO Used for Severe Respiratory Failure?
VV ECMO Indications: When Is Veno-Venous ECMO Used for Severe Respiratory Failure?
A clinical guide to the conditions that warrant VV ECMO — from refractory ARDS and chest trauma to severe lung infections — and what patients and families in Jaipur need to know.
By the Apex Hospitals Clinical Team · Published July 2025
What Is VV ECMO and Why Does It Matter?
Veno-Venous Extracorporeal Membrane Oxygenation — commonly called VV ECMO — is a form of advanced life support that takes over the work of the lungs when they can no longer transfer enough oxygen into the bloodstream, even with the help of a mechanical ventilator. Unlike Veno-Arterial (VA) ECMO, which supports both the heart and lungs, VV ECMO is specifically designed for patients whose cardiac function remains intact but whose lungs have failed critically.
In VV ECMO, blood is drained from a large vein, passed through an external membrane oxygenator that adds oxygen and removes carbon dioxide, and then returned to the venous circulation — allowing the native lungs time to rest and recover. The procedure is not a cure in itself; it is a bridge — buying precious days or weeks for the underlying lung injury to heal, for an infection to be treated, or for a definitive intervention to be planned.
At Apex Hospitals' ECMO programme in Jaipur, the team has achieved an 80% survival rate in ECMO cases — among the strongest outcomes in Rajasthan — supported by both Veno-Venous and Veno-Arterial ECMO machines and a dedicated ICU and critical care unit with round-the-clock intensivist cover.
Understanding the Spectrum of Respiratory Failure
Before exploring specific VV ECMO indications, it helps to understand how clinicians classify respiratory failure. Hypoxaemic respiratory failure (Type 1) occurs when the lungs cannot oxygenate blood adequately, while hypercapnic respiratory failure (Type 2) involves a build-up of carbon dioxide. VV ECMO addresses both, but it is most commonly deployed for severe Type 1 failure — particularly when the ratio of arterial oxygen partial pressure to the fraction of inspired oxygen (PaO₂/FiO₂ ratio) falls below 80 mmHg despite optimal ventilator settings, as outlined in the Extracorporeal Life Support Organization (ELSO) guidelines.
The decision to initiate VV ECMO is never taken lightly. It requires a multidisciplinary team — intensivists, pulmonologists, cardiac surgeons, and perfusionists — to weigh the severity of lung failure against the patient's overall prognosis, reversibility of the underlying condition, and absence of absolute contraindications.
Primary Indications for VV ECMO
1. Severe Acute Respiratory Distress Syndrome (ARDS)
ARDS is the most common indication for VV ECMO worldwide. It is characterised by widespread lung inflammation, fluid accumulation in the air sacs, and a dramatic drop in oxygenation. Causes include sepsis, pneumonia, aspiration, pancreatitis, and major trauma. The landmark CESAR trial (published in The Lancet) and subsequent EOLIA trial data demonstrated that transferring patients with severe ARDS to ECMO-capable centres significantly improved 60-day survival compared with conventional ventilation alone.
VV ECMO is typically considered in ARDS when:
PaO₂/FiO₂ ratio is <80 mmHg on FiO₂ ≥0.8 for more than 6 hours
PaOâ‚‚/FiOâ‚‚ ratio is <50 mmHg for more than 3 hours
pH <7.25 with PaCO₂ ≥60 mmHg for more than 6 hours despite optimal ventilator management
Ventilator settings are causing unacceptable barotrauma or volutrauma
The goal is to allow lung-protective ventilation — using very low tidal volumes and pressures — while ECMO handles gas exchange, giving the injured lung tissue the best chance to recover.
2. Severe Pneumonia and Viral Lung Infections
Severe community-acquired pneumonia, influenza pneumonitis, and — as the world witnessed during the COVID-19 pandemic — viral pneumonia can cause a degree of lung injury indistinguishable from ARDS. When high-flow oxygen, prone positioning, and mechanical ventilation fail to maintain safe oxygen levels, VV ECMO becomes a critical rescue option.
During the COVID-19 pandemic, ECMO centres globally reported that carefully selected patients with refractory COVID-19 ARDS had survival rates comparable to pre-pandemic ECMO cohorts, reinforcing the value of this technology in viral lung injury. The pulmonary medicine team at Apex Hospitals works closely with the ECMO unit to identify patients who may benefit before the window for intervention closes.
3. Chest Trauma and Pulmonary Contusion
High-energy chest trauma — from road traffic accidents, falls from height, or crush injuries — can cause severe pulmonary contusion, haemothorax, pneumothorax, and rib fractures that collectively devastate lung function. In these patients, conventional ventilation may be both inadequate for oxygenation and harmful, as high pressures worsen already-injured lung tissue.
VV ECMO in chest trauma serves a dual purpose: it maintains oxygenation while allowing the surgical team to manage thoracic injuries without the constraint of ventilator dependency. The emergency and trauma team at Apex Hospitals Jaipur is equipped to initiate ECMO rapidly in the trauma setting, with Emergency OTs available 24×7 and an on-site Trauma ICU.
4. Status Asthmaticus Refractory to Conventional Therapy
Near-fatal asthma attacks that do not respond to bronchodilators, systemic steroids, magnesium sulphate, and mechanical ventilation can lead to life-threatening hypercapnia and respiratory acidosis. In this rare but critical scenario, VV ECMO can correct the carbon dioxide build-up and acidosis while the medical team continues aggressive bronchodilator therapy, allowing the bronchospasm to resolve without the patient suffering anoxic brain injury.
5. Bridge to Lung Transplantation
For patients with end-stage lung disease — such as idiopathic pulmonary fibrosis or cystic fibrosis — who are awaiting a donor lung, VV ECMO can serve as a bridge to transplantation. It maintains adequate oxygenation and, in some protocols, allows the patient to remain awake and ambulatory ("awake ECMO"), preserving muscle strength and improving post-transplant outcomes.
6. Inhalation Injury and Chemical Lung Injury
Inhalation of toxic gases, smoke, or chemical agents can cause acute chemical pneumonitis with rapid progression to respiratory failure. When the injury is severe enough to overwhelm ventilator support, VV ECMO provides a lifeline while the lung epithelium regenerates over days to weeks.
How Clinicians Decide: The ELSO Criteria and Beyond
The decision to cannulate a patient for VV ECMO is guided by internationally recognised criteria — primarily those published by the Extracorporeal Life Support Organization — but it is ultimately a clinical judgement that integrates objective thresholds with the patient's overall trajectory, comorbidities, and the reversibility of the lung injury.
Key inclusion considerations include:
Severe, potentially reversible respiratory failure unresponsive to optimal conventional management
Murray Lung Injury Score ≥3.0 or pH <7.20 with hypercapnia
Failure of prone positioning, neuromuscular blockade, and recruitment manoeuvres
Absence of absolute contraindications (e.g., unrecoverable underlying disease, prolonged high-pressure ventilation >7 days, severe neurological injury)
Timing is critical. Evidence consistently shows that earlier initiation of ECMO — before prolonged high-pressure ventilation causes additional ventilator-induced lung injury — is associated with better outcomes. This is why rapid referral to an ECMO-capable centre like Apex Hospitals is essential when conventional therapy is failing.
What Happens During VV ECMO: The Care Pathway
Understanding the process can help patients and families feel more prepared. Here is a simplified overview of what VV ECMO involves:
Assessment and consent: The ECMO team — comprising intensivists, cardiac surgeons, and perfusionists — evaluates the patient and discusses the procedure with the family.
Cannulation: Under sedation, large cannulas are inserted into major veins (typically the femoral and internal jugular veins) to connect the patient to the ECMO circuit.
Circuit initiation: Blood flows from the patient through the membrane oxygenator, where oxygen is added and COâ‚‚ is removed, before being returned to the body.
ICU monitoring: The patient remains in the ICU under continuous monitoring. Anticoagulation is carefully managed to prevent clotting in the circuit while minimising bleeding risk.
Weaning: As the lungs recover, ECMO support is gradually reduced. Once the patient can maintain adequate oxygenation independently, the cannulas are removed.
At Apex Hospitals, the Advanced ICU with ECMO capability is supported by the HOPE Tele-ICU Command Centre — a 24×7 remote monitoring platform connecting 18 partner sites across Rajasthan — ensuring that super-specialty critical care expertise is available even when patients are transferred from distant locations.
VV ECMO at Apex Hospitals, Jaipur: What Sets Us Apart
Proven outcomes: An 80% survival rate in ECMO cases — among the strongest in Rajasthan — backed by both VV and VA ECMO machines.
Integrated critical care infrastructure: Dedicated Cardiac ICU, Trauma ICU, and Neuro ICU, with CRRT machines for patients who develop concurrent acute kidney injury during ECMO.
HOPE Tele-ICU Command Centre: 24×7 remote intensivist oversight connecting 18 partner sites, reducing the cost burden on families by ₹40,000–₹50,000 per day compared with inter-city transfers.
NABH accreditation: All ECMO protocols adhere to NABH-accredited quality and safety standards.
Multidisciplinary collaboration: The cardiothoracic surgery team works alongside pulmonologists, intensivists, and the vascular surgery department to manage complex ECMO cases end-to-end.
Harvard Business Review recognition: Apex Hospitals' HOPE Tele-ICU Programme has been featured in the Harvard Business Review, reflecting the global credibility of the hospital's critical care innovation.
Conditions That May Preclude VV ECMO
Not every patient with respiratory failure is a candidate for VV ECMO. Absolute contraindications generally include conditions where ECMO cannot meaningfully improve the outcome:
Irreversible underlying disease with no prospect of recovery or transplantation
Prolonged high-pressure mechanical ventilation (>7 days) causing irreversible ventilator-induced lung injury
Severe, unrecoverable neurological injury
Active, uncontrolled bleeding or conditions that preclude anticoagulation
Advanced malignancy with limited life expectancy
Relative contraindications — such as obesity, advanced age, or immunosuppression — are weighed individually. The ECMO team at Apex Hospitals conducts a thorough case-by-case assessment, ensuring that the intervention is offered only when it can genuinely improve the patient's chance of survival and recovery.
Recognising When to Seek Help: Signs That Conventional Ventilation May Be Failing
For families of critically ill patients in Jaipur and across Rajasthan, knowing when to ask about ECMO can be life-saving. Speak to the treating intensivist or request an ECMO consultation if your loved one:
Remains on a ventilator with worsening oxygen levels despite maximum settings
Has been diagnosed with severe ARDS, severe pneumonia, or significant chest trauma
Is deteriorating despite prone positioning and other rescue ventilation strategies
Has a potentially reversible lung condition (infection, trauma, inflammation) but is not improving
Early referral to an ECMO centre is consistently associated with better outcomes. The ECMO specialists at Apex Hospitals are available for urgent consultations and can advise on whether transfer and ECMO initiation is appropriate — even for patients currently managed at other facilities through the HOPE Tele-ICU network.
The Role of Rehabilitation After VV ECMO
Surviving ECMO is a remarkable achievement, but recovery does not end when the cannulas are removed. Many patients experience significant physical deconditioning, respiratory muscle weakness, and psychological sequelae — collectively termed Post-Intensive Care Syndrome (PICS). A structured rehabilitation programme is essential.
Apex Hospitals' in-house physiotherapy and rehabilitation unit works with post-ECMO patients from the earliest stages of recovery — beginning with passive mobilisation in the ICU and progressing to active exercise, breathing retraining, and functional rehabilitation. This continuum of care, from ECMO initiation to discharge and beyond, is central to the Apex Hospitals approach.
Frequently Asked Questions
Is VV ECMO the same as being on a heart-lung machine?
Not exactly. A heart-lung bypass machine (cardiopulmonary bypass) is used during open-heart surgery and takes over both heart and lung function temporarily. VV ECMO supports only the lungs and is designed for prolonged use — days to weeks — in the ICU. The patient's heart continues to pump blood normally during VV ECMO.
How long can a patient remain on VV ECMO?
Most patients are supported on VV ECMO for 1–4 weeks, though some cases — particularly those bridging to lung transplantation — may require longer durations. The ECMO team monitors circuit integrity, anticoagulation, and the patient's lung recovery daily to determine the optimal weaning timeline.
What are the main risks of VV ECMO?
The principal risks include bleeding (due to necessary anticoagulation), clot formation in the circuit, infection, limb ischaemia at the cannulation site, and neurological complications. These risks are carefully managed by the ECMO team through continuous monitoring, circuit checks, and anticoagulation protocols. The risk-benefit balance is always discussed with the family before initiation.
Can patients be transferred to Apex Hospitals for ECMO from other cities in Rajasthan?
Yes. Apex Hospitals has equipped ambulance services and the HOPE Tele-ICU Command Centre facilitates pre-transfer consultation and coordination. Patients from Sawai Madhopur, Jhunjhunu, Bikaner, Sri Ganganagar, Udaipur, and beyond have been successfully transferred for ECMO care. Early contact with the ECMO team is strongly recommended to plan safe transfer.
Is ECMO covered under Ayushman Bharat or insurance?
Apex Hospitals is empanelled under Ayushman Bharat and major insurance and TPA schemes. Coverage for ECMO varies by policy and scheme. The hospital's patient services team can assist families in verifying eligibility and processing claims promptly.
References
Is Your Patient a Candidate for VV ECMO?
If a loved one is on a ventilator with worsening lung function, speak to our ECMO specialists at Apex Hospitals Jaipur — early consultation can make a critical difference.